Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SCYX
SCYX logo

SCYX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

SCYX News

SCYNEXIS Announces 1-for-8 Reverse Stock Split

May 22 2026seekingalpha

SCYNEXIS Announces Reverse Stock Split Plan

May 22 2026Newsfilter

SCYNEXIS Completes Acquisition of SCY-770 for ADPKD Treatment

May 11 2026Newsfilter

SCYNEXIS Approves Inducement Equity Awards for New VP

May 07 2026Newsfilter

U.S. March Manufacturing PMI Slightly Rises

Apr 01 2026seekingalpha

SCYNEXIS Secures $40M in Securities Purchase Agreement

Mar 31 2026seekingalpha

Scynexis Acquires Kidney Disease Treatment, Shares Surge

Mar 31 2026stocktwits

Poxel SA Sells Drug Candidate PXL770 to Scynexis for Up to $196 Million

Mar 31 2026NASDAQ.COM

SCYX Events

05/29 20:00
Scynexis Trading Halted, News Pending
Scynexis trading halted, news pending
05/11 16:30
Company Cash and Investments Total $72.4 Million
Cash, cash equivalents and investments totaled $72.4M on March 31, compared to $56.3M on December 31, 2025. The balance at March 31 includes approximately $24M of the gross proceeds of $40M from the private placement that closed on April 1 with certain new and existing institutional and accredited investors. The March 31 balance plus the approximately $16M in gross proceeds received on April 1 extends the company's cash runway to mid-2029.
05/01 16:10
Scynexis Files to Sell 87M Shares of Common Stock
Scynexis files to sell 87M shares of common stock for holders

SCYX Monitor News

SCYNEXIS Inc stock rises amid market gains

Mar 31 2026

SCYX Earnings Analysis

No Data

No Data

People Also Watch